Dr. Patrick Lorenz
Nutrition in industrialized countries will move away from meat and dairy consumption towards alternative sources of protein and foods. These will rely on plants, microorganisms and cell cultures. Biotechnology will be the key enabler. This is where we come in.
Our DOLCE R&D program was completed at the end of 2020, and gave rise to two approaches for BRAIN and the food industry.
Probiotics (Latin “for life”) are living microorganisms having a health-promoting effect on humans and animals. With our proprietary collection of probiotic strains and a broad portfolio of technologies, we can be your partner for evidence-based development of probiotic products for various applications and markets.
Edible plants provide bioactive compounds that combat harmful organisms. BRAIN’s FRESCO program identifies the best anti-microbial candidates.
Based on special cell-based test systems, we offer our scientific services for substance testing and salt sensing.